Toxicogenomic biomarkers for renal papillary injury in rats

Takeki Uehara1, Chiaki Kondo, Yuji Morikawa

  • 1Drug Developmental Research Laboratories, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan. takeki.uehara@shionogi.co.jp

Toxicology
|November 13, 2012
PubMed

Insights

Researchers identified novel genomic biomarkers for early detection of renal papillary injury in rats. Top candidates like Timp1, Igf1, and Lamc2 show high accuracy in predicting kidney damage.

Area of Science:

  • Toxicology
  • Genomics
  • Drug Development

Background:

  • Renal papillary injury is a frequent adverse effect in drug development.
  • Early and sensitive detection methods are crucial for patient safety.

Purpose of the Study:

  • To identify genomic biomarkers for early and sensitive detection of renal papillary injury in rats.
  • To evaluate the applicability of known tubular injury biomarkers for papillary injury detection.

Main Methods:

  • Analysis of 18 candidate gene expression profiles using RT-PCR in different rat kidney regions.
  • Utilized receiver operator characteristic (ROC) analysis to identify predictive biomarkers.
  • Validated biomarker performance using an independent dataset and machine learning models.

Main Results:

  • Several genes were commonly upregulated or downregulated in the renal papilla, indicating papillary injury.
  • Six candidate biomarkers were identified, with Timp1, Igf1, and Lamc2 showing the highest predictive performance (AUC > 0.91).
  • An optimized support vector machine model using three genes achieved an AUC of 0.99.

Conclusions:

  • Identified genes, particularly Timp1, Igf1, and Lamc2, are promising genomic biomarkers for renal papillary injury in rats.
  • Further validation studies are necessary to establish their clinical utility and reliability.
  • These biomarkers could significantly improve early detection of drug-induced kidney damage.

Related Concept Videos